89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

Historical Holders from Q4 2019 to Q3 2025

Symbol
ETNB
CUSIP
282559103
Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
148M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
155M
Holdings value
$2.27B
% of all portfolios
0.01%
Grand Portfolio weight change
0%
Number of holders
194
Number of buys
112
Number of sells
-103
Average Value change %
+0%
Average buys %
+0.007%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Deep Track Capital, LP 6.31% -31.9% $138M -$65.6M 9.36M -32.3% Deep Track Capital, LP Sep 30, 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.6% -43% $122M -$93.1M 8.28M -43.3% SUVRETTA CAPITAL MANAGEMENT, LLC Sep 30, 2025
VANGUARD GROUP INC 5.64% $80.9M 8.24M The Vanguard Group Jun 30, 2025
JANUS HENDERSON GROUP PLC 3.6% -75.7% $79.1M -$227M 5.38M -74.1% JANUS HENDERSON GROUP PLC Sep 30, 2025
BIOTECHNOLOGY VALUE FUND L P 3.6% $29.9M 4.33M BVF PARTNERS L P/IL Dec 31, 2024
RTW INVESTMENTS, LP 1.3% $13.6M 1.97M RTW Investments, LP Mar 31, 2025

Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 155M $2.27B -$1.5M $14.70 194
2025 Q2 161M $1.58B +$87.3M $9.82 181
2025 Q1 154M $1.14B +$236M $7.27 184
2024 Q4 121M $948M +$129M $7.82 152
2024 Q3 104M $773M +$3.7M $7.40 143
2024 Q2 103M $827M +$24.7M $8.01 143
2024 Q1 97.7M $1.14B +$49.2M $11.64 149
2023 Q4 93.6M $1.05B +$191M $11.17 151
2023 Q3 71.9M $1.11B -$105M $15.44 165
2023 Q2 77.2M $1.46B +$132M $18.95 157
2023 Q1 71M $1.08B +$393M $15.23 149
2022 Q4 46.3M $589M +$135M $12.73 106
2022 Q3 39.2M $227M +$45.5M $5.79 85
2022 Q2 32.5M $105M +$48M $3.22 67
2022 Q1 17.1M $64.3M -$14.9M $3.77 65
2021 Q4 17.3M $226M -$710K $13.07 49
2021 Q3 17.3M $339M +$9.16M $19.59 48
2021 Q2 16.9M $315M -$5.58M $18.70 50
2021 Q1 16.9M $401M +$4.52M $23.68 67
2020 Q4 16.7M $407M +$14.9M $24.37 69
2020 Q3 16M $411M +$130M $25.66 68
2020 Q2 10.4M $207M -$1.58M $19.93 36
2020 Q1 10.7M $270M +$7.52M $25.25 30
2019 Q4 10.4M $275M +$272M $26.29 34